Share

The pharma industry briefing

The latest news, approvals and clinical trials you need to know about this month

Data: 
News in Numbers

Data: News in Numbers

 16%

FDA new drug approvals down 16% in 2019, according to research from GlobalData

10%  

CEPI has invested $384m in Novavax‘s COVID-19 vaccine candidate

 $384m

5

Gilead is granting five generic drug manufacturers the rights to manufacture remdesivir

€45m

Norway’s BerGenBio has raised approximately €45.4m develop its pipeline

 40

This year marks the 40th anniversary of the eradication of smallpox

Data: News in Numbers

16% 

FDA new drug approvals down 16% in 2019, according to research from GlobalData

$384m

CEPI has invested $384m in Novavax‘s COVID-19 vaccine candidate

  5 

Gilead is granting five generic drug manufacturers the rights to manufacturer remdesivir

€45m

Norway’s BerGenBio has raised approximately €45.4m develop its pipeline 

40

This year marks the 40th anniversary of the eradication of smallpox

 Arthritis drug may improve respiratory function in some patients with severe COVID-19

A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe Covid-19. 

Source: World Pharma News

 Pharma shipments lift Singapore exports for third straight month

Singapore's annual exports rose for the third straight month in April, bolstered by a sharp rise in pharmaceutical shipment.

Source: Yahoo

 Spike in cyber-crime activity sparks official warning to Pharma industry

The UK’s National Cyber Security Centre along with the American Department of Homeland Security’s CISA have issued a specific warning to pharmaceutical companies, medical research organisations and universities.

Source: Two Birds

 Trump says former Lilly exec will lead “Operation Warp Speed”

President Trump has named former GlaxoSmithKline executive Moncef Slaoui as chief adviser to "Operation Warp Speed", an effort to speed up development of a vaccine for COVID-19 in the US.

Source: Pharma Manufacturing

Approvals

 Remdesivir

Gilead Sciences has received approval from the Japanese Ministry of Health, Labour and Welfare for its antiviral drug remdesivir to treat Covid-19 infection.

Source: Pharmaceutical Technology

Farxiga

The US Food and Drug Administration has approved AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular death and hospitalisation for heart failure in adults with heart failure with reduced ejection fraction.

Source: Pharmaceutical Technology

Qinlock (ripretinib) Tablets

Qinlock (ripretinib) is a broad-spectrum KIT and PDGFRα inhibitor for the treatment of patients with advanced gastrointestinal stromal tumour who have received prior treatment with three or more kinase inhibitors, including imatinib.

Source: FDA 

Fensolvi (leuprolide acetate) Injection

Fensolvi (leuprolide acetate) is a gonadotropin releasing hormone agonist indicated for the treatment of paediatric patients two years of age and older with central precocious puberty.

Source: Biospace

Share this article